32
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Regulation of endometrial angiogenesis

, , &
Pages 52-58 | Received 12 Nov 1998, Accepted 19 Feb 1999, Published online: 03 Jul 2009

References

  • Hope S, Rees M CP. Why do British women start and stop hormone replacement therapy?. J Br Meno Soc 1995; 1: 26–7
  • Hope S, Wager E, Res M CP. Survey of British women's views on the menopause and HRT. J Br Meno Soc 1998; 4: 33–6
  • Sturdee D W. Newer HRT regimens. Br J Obstet Gynaecol 1997; 104: 1109–15
  • Goodger (Macpherson) A, Rogers P AW. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod 1994; 9: 399–405
  • Rees M CP, Bicknell R. Angiogenesis in the endometrium. Angiogenesis 1998; 2: 29–35
  • Leopold G. Studien ueber die uterusschlamhaut waehrend der menstruation, schwanger-schaft und wochenbett. Arch F Gynak 1877; 11: S110, cited in Daron GH The arterial pattern of the tunica mucosa of the uterus in macacus rhesus. Am J Anat 1936; 58:349–58
  • Markee J E. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib Embryol Carnegie Inst 1940; 28: 219–308
  • Kaiserman-Abramof I R, Padykula H A. Angiogenesis in the postovulatory primate endometrium: the coiled arteriolar system. Anat Res 1989; 224: 479–89
  • Perrot-Applanat M, Groyer-Picard M T, Garcia E, Lorenzo F, Milgrom E. Immunocytochemical demonstration of oestrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988; 123: 1511–19
  • Smith K, Lejeune S, Harris A L, Rees M CP. Epidermal growth factor receptor in human uterine tissues. Hum Reprod 1991; 6: 619–22
  • Tabibzadeh S. Human endometrium: an active site of cytokine production and action. Endocr Rev 1991; 12: 272–90
  • Charnock-Jones D S, Sharkey A M, Rajput-Williams J, et al. Identification and localisation of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and oestrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993; 48: 1120–8
  • Ferriani R A, Charnock-Jones D S, Prentice A, Thomas E J, Smith S K. Immunohistochemical localisation of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 1993; 8: 11–16
  • Cullinan-Bove K, Koos R D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993; 131: 2173–81
  • Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91: 2235–43
  • Iruela-Arispe M L, Porter P, Bornstein P, Sage E H. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 1996; 97: 403–12
  • Zhang L, Rees M CP, Bicknell R. The isolation and long term culture of normal human endometrial epithelium and stroma: expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progestogen challenge. J Cell Sci 1995; 108: 323–31
  • Zhang L, MacKenzie I Z, Rees M CP, Bicknell R. Regulation of the expression of the angiogenic enzyme platelet derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 1997; 138: 4921–30
  • Zhang L, Scott P AE, Turley H, et al. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol 1998; 185: 402–8
  • Casslen B, Sandberg T, Gustavsson B, Willen R., Nilbert M. Transforming growth factor beta 1 in the human endometrium. Cyclic variation, increased expression by oestradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol Reprod 1998; 58: 1343–50
  • Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees M CP. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998; 16: 409–15
  • Kothapalli R., Buyuksal I, Chegigni K., Tabibzadeh S. Detection of ebaf, a novel human gene of the transforming growth factor β superfamily. J Clin Invest 1997; 99: 2342–50
  • Maisonpierre P C, Suri C, Jones P F, et al. Angiopoitin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55–60
  • Rutanen E-M, Salmi A, Nyman T. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGFII and IGF-binding protein-1 are constantly expressed in the endometrium during the use of an intrauterine levonorgestrel system. Mol Hum Reprod 1997; 9: 749–54
  • Fernandez-Shaw S, Shorter S C, Naish C E, Barlow D H, Starkey P M. Isolation and purification of human endometrial stromal and glandular cells using immunomagnetic beads. Hum Reprod 1992; 7: 156–61
  • Tabibzadeh S, Kaffka K L, Kilian P L, Satyaswaroop P. Human endometrial epithelial cell lines for studying steroid and cytokine action. In Vitro Cell Dev Biol 1990; 26: 1173–9
  • Nishida M, Kasahara K, Kaneko M, Iwasaki H. Establishment of a new endometrial adenocarcinoma cell line, Ishikawa cells, containing oestrogen and progesterone receptors. Acta Obstet Gynecol Jpn 1985; 37: 1103–11
  • Endothelial cell culture. Handbooks in Practical Animal Cell Biology, R Bicknell. Cambridge University Press, Cambridge 1996
  • Grimwood J, Bicknell R, Rees M CP. The isolation, characterisation and culture of human decidual endothelium. Hum Reprod 1995; 10: 2142–8
  • Rees M CP, Heryet A R, Bicknell R. Immunohistochemical properties of the endothelial cells in the human uterus during the menstrual cycle. Hum Reprod 1993; 8: 1173–8
  • Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996; 92: 2576–81
  • Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290–8
  • Yamada Y, Nezu J, Shimane M, Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 1997; 42: 483–8
  • Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico M G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267–71
  • Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (London) 1996; 380: 435–9
  • Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (London) 1996; 380: 439–42
  • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25
  • Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 1992; 359: 843–5
  • Bausero P, Caville F, Meduri G, Freitas S, Perrot-Applanat M. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 1998; 2: 167–82
  • Li X F, Gregory J, Ahmed A. Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors 1994; 11: 277–82
  • Kato S, Tora L, Yamauchi J, Masushige S, Bellard M, Chambon P. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 1992; 68: 731–42
  • Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947–54
  • Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes [letter]. Nature (London) 1994; 368: 198
  • Zhang L. Mechanistic studies of endometrial angiogenesis. DPhil Thesis, Oxford University. 1997
  • Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–60
  • Kitamura K, Sakata J, Kangawa K, Kojima M., Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720–5
  • Eguchi S, Hirata Y, Iwasaki H, et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994; 135: 2454–8
  • Ishimitsu T, Kojima M, Kangawa K, et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–9
  • Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1994; 203: 719–26
  • Martinez A, Elshasser T, Muro-Cacho C, et al. Expression of adrenomedullin and its receptor in normal and malignant skin: a potential pluripotent role in the integument. Endocrinology 1997; 138: 5597–604
  • Miller M J, Martinez A, Unsworth E J, et al. Adrenomedullin expression in human tumor cell lines, its role as an autocrine growth factor. J Biol Chem 1996; 271: 23345
  • Withers D J, Coppock H A, Seufferlein T, Smith D M, Bloom S R, Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS LETT 1996; 378: 83–7
  • Fan T-PD, Hu D E, Hiley C R. Angiogenesis in Health and Disease. Plenum Press, New York 1992; 317–32
  • Webb P, Lopez G N, Uht R M, Kushner P J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995; 9: 443–56
  • Hourihan M A, Sheppard B L, Brosens I A. Endometrial haemostasis. Contraception and Mechanisms of Endometrial Bleeding, C D'Arcangues, I S Fraser, J Newton, V Odlind. Cambridge University Press, Cambridge 1990; 95–114
  • Rogers P AW, Au C L, Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod 1993; 9: 1396–404
  • Goodger A M, Rogers P AW, Affandi B. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Hum Reprod 1993; 9: 1647–51
  • Subakir S B, Hadipustra W, Handoyo A E, et al. Endometrial angiogenic response in Norplant users. Hum Reprod 1996; 11: 51–5, (Suppl 2)
  • Song J Y, Markham R, Russell P, et al. The effect of high dose medium and long-term progestogen exposure on endometrial vessels. Hum Reprod 1995; 10: 797–800
  • Hickey M, Lau T M, Russell P, Fraser I S, Rogers P AW. Microvascular density in conditions of endometrial atrophy. Hum Reprod 1996; 11: 2009–13
  • Schifren J, Tseng J, Zaloudek C J. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81: 3112–18
  • Yamamoto T, Terada N, Nishizawa Y, Petrow V. Angiostatic activities of medroxyprogesterone acetate and its analogues. Int J Cancer 1994; 56: 393–9
  • Peek M J, Markham R, Fraser I S. The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation. Hum Reprod 1995; 10: 2238–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.